Based on the results of the NLST , the US Preventative Services Task Force (USPSTF) has affirmed its recommendation regarding the value of low-dose computed tomography (CT) scans in finding early lung cancer . The next steps entail ensuring provisions for appropriate reimbursement followed by national implementation of this screening service. From a clinical perspective, low-dose CT management is quite different from existing management strategies of clinically detected lung cancer. Therefore the transition to this new management approach may be challenging. Inherent in the emergence of lung cancer screening as a recommended service is that the optimal organizational structure to provide this service is not fully defined. Recent articles have outlined how risk stratification and diagnostic work-ups as well as surgical interventions can be refined to further improve screening outcomes [1,3,4].